According to an article from Medical News Today, a popular diabetes drug appears to help patients with different types of cancer.
In two different studies performed, the drug metformin (brand name Glucophage) was shown to prolong life expectancy for patients with early-stage pancreatic cancer, help prevent primary liver cancer, and slow down prostate growth.
Researchers have revealed the findings to the American Association for Cancer Research at the conference held in Chicago this past week.
Other research shows that metformin may also benefit those with oral cancer and possibly help with some types of melanoma.
Snyder and Wenner, P.V.
602-224-0005
No comments:
Post a Comment